Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129105) titled 'Pharmacokinetics, Bioequivalence, and Safety of Two Formulations of Toremifene Citrate Tablets in Healthy Chinese Participants Under Fasted and Fed Conditions' on July 31.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Bishan Hospital of Chongqing medical university,Bishan Hospital of Chongqing
Condition:
Metastatic breast cancer in postmenopausal women with estrogen receptor-positive or unknown status
Intervention:
Fed group:Healthy volunteers were randomized into two 15-participant crossover sequences. A washout period of =28 days separated the two treatment cycles. In Cycle 1,...